Le Lézard
Classified in: Health, Science and technology
Subjects: PER, PET, MAT

ElleVet Sciences Announces Expansion of Executive Leadership Team


Haley Israelson Promoted to Chief Financial Officer and Ryan Shadrin Appointed to Chief Commercial Officer

SOUTH PORTLAND, Maine, March 19, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences, the first company to prove the safety and efficacy of its hemp-based CBD products for pets, announces the recent expansion of its executive leadership team with the promotion of Haley Israelson to Chief Financial Officer, and addition of Ryan Shadrin as Chief Commercial Officer.

"I'm proud to be part of a rapidly growing company that is revolutionizing the animal health industry by developing safe, effective solutions to improve the health and wellness of pets. Our commitment to making a lasting impact on pets' lives is at the core of our mission."

Israelson, who previously served as VP of Finance, Operations & Ecommerce, assumed the role of Chief Financial Officer in January and now leads the company's accounting, finance, and treasury functions. Prior to joining ElleVet, Israelson served as a finance and investment professional in the venture capital and private equity space, where she worked with numerous high growth startups. Haley is a Certified Public Accountant in the State of Maine who earned her MBA and BS in Accounting from Husson University.

"I'm proud to be part of a rapidly growing company that is revolutionizing the animal health industry by developing safe, effective solutions to improve the health and wellness of pets. Our commitment to making a lasting impact on pets' lives is at the core of our mission," Israelson explained. "My journey with ElleVet has been one of personal and professional growth, and I'm excited to continue driving innovation and creating significant value with the ElleVet team."

Shadrin joins ElleVet as Chief Commercial Officer leading the company's ecommerce, marketing, customer experience, and sales teams. With over 25 years of marketing and operator experience, Shadrin has held the roles of Chief Marketing Officer, Chief Revenue Officer, and Global VP of Direct to Consumer for companies ranging from start-ups to multi-billion dollar, publicly traded corporations. Ryan holds a BA in History from Hamilton College and certification in AI and Machine Learning from Stanford School of Engineering.

"Just as ElleVet has applied scientific rigor to the development of the most vet recommended CBD + CBDA pet health supplements, I aim to apply data science and analytics to build market share, personalize the customer journey, and maximize revenue opportunities," Shadrin shared. "This synthesis of science and strategy will drive our mission forward, ensuring that every decision enhances our ability to make a real difference in the lives of pets and their families."

The expansion of the ElleVet leadership team is a key milestone in the company's strategic growth plan. "We are excited to announce the promotion of Haley and the hiring of Ryan as we continue to grow ElleVet Sciences and explore the role of cannabinoids in animal health," said Christian Kjaer, CEO and Co Founder of ElleVet Sciences. "Haley and Ryan will play integral roles in ElleVet's leadership and future. Their unique and impressive expertise, passion, and energy will have a strong impact on ElleVet's strategic goals and future growth."

Media Contact

Christian Kjaer, CEO and Co Founder, ElleVet Sciences, 1 (844) 673-7287, [email protected], https://www.ellevetsciences.com/

SOURCE ElleVet Sciences


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: